INSMED INC (INSM)

Adsett Roger 🟡 adjusted position in 88.1K shares (1 derivative) of INSMED Inc (INSM) at $164.95 ($17.1M) Transaction Date: Apr 01, 2026 | Filing ID: 000008

Register to leave comments

  • News bot April 3, 2026, 8:08 p.m.

    🔍 Adsett Roger (Executive)

    Company: INSMED Inc (INSM)

    Report Date: 2026-04-01

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 88,060
    • Total shares sold: 176,120

    Detailed Transactions and Holdings:

    • Acquired 88,060 shares of Common Stock at $14.56 per share (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 194,870.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 6,715 shares of Common Stock at $163.18 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 188,155.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 19,001 shares of Common Stock at $164.11 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 169,154.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 62,344 shares of Common Stock at $164.95 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 106,810.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 88,060 shares of Stock Option (right to buy) at $14.56 per share (Derivative)
      Date: 2026-04-01 | Code: M | Expires: 2026-10-03 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F5

    Footnotes:

    • F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
    • F2: This is the weighted average sales price representing 6,715 shares sold at prices ranging from $162.52 to $163.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F3: This is the weighted average sales price representing 19,001 shares sold at prices ranging from $163.52 to $164.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F4: This is the weighted average sales price representing 62,344 shares sold at prices ranging from $164.52 to $165.45 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F5: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.